Results 141 to 150 of about 1,323 (215)

Toward Monitoring and Addressing the Commercial Determinants of Health: Where Can We Go From Here? [PDF]

Milbank Q
Burgess R, Srebotnjak T, Lin C, Grierson L, Esty DC, Ransome Y, Freudenberg N.   +6 more
europepmc   +1 more source

It is time for a more nuanced discussion about pharmacy benefit managers. [PDF]

J Manag Care Spec Pharm
Cantrell SA.
europepmc   +1 more source

Balancing Scientific and Commercial Interests: The European Health Data Space Response to Commercial Scientific Research. [PDF]

Inquiry
Yao X, Sun Z, Man H.
europepmc   +1 more source

The impacts of pricing and reimbursement policies on access to cell and gene therapies across Europe. [PDF]

J Community Genet
Han Y, Andreoletti M, Minssen T, Vayena E, Ormond KE.   +4 more
europepmc   +1 more source

In Defense of Using Medical Practice Guidelines Defensively: A Response to Stewart and Peck. [PDF]

Am J Law Med
Hall MA.
europepmc   +1 more source

Safeguarding the right to collective bargaining in the face of precarious self-employment - Gaps in Protection in Austria and Germany and obligations under European law. [PDF]

Eur Labour Law J
Pupeter F, Lukas K, Bertazolli C.
europepmc   +1 more source

Organizational Forms and Welfare Coalitions: Corporate Law and the Movement for Social Insurance in the US and UK. [PDF]

Br J Sociol
Adereth M.
europepmc   +1 more source

The Antitrust Laws and Monopoly

The University of Chicago Law Review, 1947
openaire   +2 more sources

Transforming the Indian Private Sector for Universal Health Coverage. [PDF]

Healthcare (Basel)
Mor N.
europepmc   +1 more source

Safety versus performance: How multi-objective learning reduces barriers to market entry. [PDF]

Proc Natl Acad Sci U S A
Jagadeesan M, Jordan MI, Steinhardt J.
europepmc   +1 more source